OBResearcher profile · from public sources
Olca Basturk
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, Sept 2026
Publication
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, Sept 2026
Publication
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer.
Journal of the National Cancer Institute, May 2026
Publication
Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma.
JCO precision oncology, Apr 2026
Publication
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.
Nature medicine, Mar 2026
Publication
Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report.
Journal of gastrointestinal oncology, Mar 2026
Publication
Intraductal neoplasms of the pancreas: Current concepts and controversies regarding definitions, evolving classifications, diagnostic challenges and clinical significance.
Seminars in diagnostic pathology, Mar 2026
Publication
Dual pancreatic carcinomas: clonally related or independent primaries?
NPJ precision oncology, Feb 2026
Publication
Metatypic Carcinoma of the Pancreas: Delineation of a Clinicopathologically Distinct Entity, Characterized by Centrally Necrotic Demarcated High-Grade Carcinoma With Divergent Patterns, Basal Immunophenotype, and Altered Molecular Profile.
The American journal of surgical pathology, Feb 2026
Publication
"Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accurate T-staging.
Histopathology, Jan 2026
Publication
Analysis of SCLC subtype markers (ASCL1, NEUROD1, POU2F3, YAP1), DLL3, OTP, and TTF1 in 300 lung carcinoids and enteropancreatic neuroendocrine tumours.
Histopathology, Jan 2026
Publication
Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling.
Cancer discovery, Dec 2025
Publication
Deep proteogenomic characterization of pancreatic solid pseudopapillary neoplasm reveals unique features distinct from other pancreatic tumors.
Biomarker research, Nov 2025
Publication
Differentiating well-differentiated neuroendocrine tumors grade 3 from poorly differentiated neuroendocrine carcinomas and adenocarcinoma with neuroendocrine differentiation: a comprehensive review.
Virchows Archiv : an international journal of pathology, Nov 2025
Publication
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
JCO precision oncology, Nov 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Irene Esposito directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error